Literature DB >> 8660053

Thalidomide treatment of mucosal ulcerations in HIV infection.

R A Solèr1, C Migliorati, H van Waes, D Nadal.   

Abstract

Pain relief and resolution of oral and perianal ulceration after treatment with thalidomide in a 14 year old girl with vertically acquired HIV infection is reported.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8660053      PMCID： PMC1511591          DOI： 10.1136/adc.74.1.64

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  4 in total

1.  Recurrent aphthous ulcers in association with HIV infection. Diagnosis and treatment.

Authors:  L A MacPhail; D Greenspan; J S Greenspan
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1992-03

2.  The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures.

Authors:  S M McHugh; I R Rifkin; J Deighton; A B Wilson; P J Lachmann; C M Lockwood; P W Ewan
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

3.  Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection.

Authors:  D L Paterson; P R Georghiou; A M Allworth; R J Kemp
Journal:  Clin Infect Dis       Date:  1995-02       Impact factor: 9.079

4.  Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.

Authors:  A L Moreira; E P Sampaio; A Zmuidzinas; P Frindt; K A Smith; G Kaplan
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307
  4 in total
  1 in total

1.  Thalidomide treatment of mucosal ulcerations in HIV infection.

Authors:  T C Harry
Journal:  Arch Dis Child       Date:  1996-07       Impact factor: 3.791
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.